• 22-Poster
  • 22-Print-Ad
  • 22-Poster_2
  • 22-Kit
  • 22-Conversion-Tool_2
  • 22-Brochure-Cover
  • 22-Brochure-Spread-1
  • 22-Brochure-Spread-3
  • 22-Brochure-Spread-2

NK22LGO_GRYBeckman Coulter discovered a significant difference between the two standard prostate cancer screening (PSA) scores, a discrepancy that could have major impact on physicians’ cancer diagnoses. The challenge was how to communicate this in a simple and powerful way.

Focusing on the difference gap of 22%, this integrated campaign was hugely successful at helping Beckman Coulter rethink vendor relationships, assure accuracy and influence care decisions.


Back to Main